Fundraising FoxVantagePoint Capital Partners — 2015 Investments
5 investments dated 2015 · listed companies and verified rows first · show all
Healthline is a digital health media platform that publishes medically reviewed content across health and wellness topics, maintained by a network of healthcare professionals and specialists.
ConsumerDigital HealthHealthtechMedia & EntertainmentSan Francisco, US
Philip Dur(Executive Officer)inMike Barber(Executive Officer)Murray Brozinsky(Executive Officer)inNaraj Katwala(Executive Officer)Jan Volfeld(Executive Officer)Cheryl Kim(Executive Officer)in
Board seatRichard Harroch· per SEC Form D
Co-investorsRed VenturesSummit Partners
New York, US
James Spanfeller(Executive Officer, Director)Aman Verjee(Chief Financial Officer)
BoardBrian Hirsch(Director)Jordan Levy(Director)Geoff Judge(Director)
Board seatRichard Harroch· per SEC Form D
Co-investorsAlpine Meridian
Gilead Sciences is a biopharmaceutical company headquartered in Foster City, California that discovers, develops, and delivers medicines across virology, oncology, and inflammation.
BiotechHealthtechMedical DevicesNewark, US
Harold Van Wart, Ph. D.(Executive Officer, Director)Pol Boudes(Executive Officer)Charles A. McWherter, Ph. D.(Executive Officer)Sujal Shah(Executive Officer)
BoardCarl Goldfischer, M.D.(Director)Kurt von Emster(Director)in
Co-investorsAvoro Capital AdvisorsBay City CapitalForesite CapitalAbingworth
YouMail is a call protection and privacy app that blocks robocalls, spam, and scam calls before they ring, and offers tools like call screening, reverse phone lookup, visual voicemail, and virtual second phone numbers.
ConsumerCybersecuritySaaSIrvine, US
Alex Quilici(Executive Officer, Director)inBrian Davi(Executive Officer)inTom Saftig(Executive Officer)inLee Weinberg(Executive Officer, Director)inMichael Rudolph(Executive Officer)
BoardEric Ver Ploeg(Director)in
Co-investorsTech Coast AngelsTuesday CapitalTunitas Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.